Form 4: Alnylam Pharmaceuticals EVP Jeffrey V. Poulton Reports Stock Transactions
SEC Form 4
EVP and CFO of Alnylam Pharmaceuticals, Jeffrey V. Poulton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On February 27, 2025, Jeffrey V. Poulton, EVP and CFO of Alnylam Pharmaceuticals, had restricted stock units vest.
- A total of 1,908 shares were acquired through the vesting of these restricted stock units.
- Simultaneously, 1,908 shares were sold to cover minimum statutory tax withholding obligations.
- On February 28, 2025, Poulton sold a total of 766 shares of common stock in multiple transactions at varying prices ranging from $236.51 to $244.32.
- Following these transactions, Poulton directly owns 33,898 shares of Alnylam common stock and indirectly owns 57 shares through a managed account.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment, as the sales are primarily for tax obligations.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be informative for investors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small volume of shares sold by the executive.
Key Dates
| Date | Description |
|---|---|
| 02/27/2023 | Reporting person was granted 5,724 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. |
| 02/27/2025 | Restricted stock units vested and shares were sold to cover tax obligations. |
| 02/28/2025 | Additional shares of common stock were sold in multiple transactions. |
| 03/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.